Enhancing Bone Health: Exploring the Role of Synbiotic Therapy
Course Description:
Explore cutting-edge research and innovative strategies for reducing bone loss with a focus on the gut-bone axis. In this webinar, leading experts Susan Bukata, MD, Chair of Orthopaedic Surgery, UCSD and Eric Schott, PhD, Co-Founder and COO of Solarea Bio, will discuss recent advancements in gut health and their implications for managing bone health in clinical settings.
Discover how enhancing gut barrier function, reducing systemic inflammation, and targeting osteoclast activity with BondiaTM (SBD111), a novel synbiotic medical food, can improve outcomes for patients at risk of bone loss.
Objectives:
- Examine the connection between gut health, systemic inflammation, and bone metabolism
- Review findings from the SBD111 clinical food trial in postmenopausal women, highlighting its role in maintaining bone mass and reducing bone resorption
- Explore how BondiaTM (SBD111) supports bone health through its impact on gut barrier function, systemic inflammation, and osteoclast activity
- Learn how to apply emerging evidence on gut-bone axis in clinical settings to improve outcomes for patients with bone health concerns
Speakers
-
Jeff Bland, PhDFunctional Medicine Founder and PioneerDr. Jeffrey Bland is a personable and highly respected thought leader who has spent more than four decades focused on the improvement of human health.
He is known worldwide as the founder of the Functional Medicine movement, which represents his vision for a care model that is grounded in systems biology and informed by research that he has a unique ability to synthesize. His pioneering work has created the Personalized Lifestyle Medicine Institute (PLMI), as well as the Institute for Functional Medicine (IFM), the global leader in Functional Medicine education. Since 1991, hundreds of thousands of healthcare practitioners have participated in PLMI and IFM programs, and this collective knowledge has positively impacted the lives of patients all over the world. -
Eric Schott, PhDCo-Founder and COO, Solarea BioAs a graduate student at the University of Rochester Medical School, Eric pioneered studies aimed at defining the role of the gut microbiome in the induction, progression, and treatment of osteoarthritis and other musculoskeletal conditions. This work set the stage for Solarea Bio’s initial focus on musculoskeletal health, where he now leads operations and clinical development of Solarea Bio products. Eric is an innovative biotechnologist driven to translate technological and scientific innovation into patient health benefits.
-
Susan Bukata, MDChair of Orthopaedic Surgery, University of California San DiegoSusan Bukata, MD, is a board-certified orthopedic surgeon internationally recognized for her expertise in bone fragility disorders, including osteoporosis and rare genetic bone diseases. Her NIH-funded research focuses on accelerating fracture healing and reducing the need for additional surgical intervention. Dr. Bukata has published extensively in leading scientific journals and holds a patent for cartilage and musculoskeletal soft tissue repair technology. She serves on several prominent boards, including the Orthopaedic Research Society Executive Board, and has been named a “Top Doctor” by Castle Connolly and other organizations. She completed advanced training in orthopedic oncology and metabolic bone disease at Memorial Sloan Kettering Cancer Center.
Sponsor
-
Journa
